Annals of Medicine
Volume 55, 2023 - Issue 1
Open access
1,948
Views
4
CrossRef citations to date
0
Altmetric
Oncology
Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors
Moustafa M. Madkoura Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates;b College of Pharmacy, University of Sharjah, Sharjah, United Arab EmiratesView further author information
, Wafaa S. Ramadana Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab EmiratesCorrespondence[email protected]
View further author information
, View further author information
Ekram Salehc Clinical Biochemistry and Molecular Biology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, EgyptView further author information
& Raafat El-Awadya Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates;b College of Pharmacy, University of Sharjah, Sharjah, United Arab EmiratesCorrespondence[email protected]
View further author information
View further author information
Article: 2203946
|
Received 25 Jan 2023, Accepted 12 Apr 2023, Published online: 24 Apr 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.